AVITA Medical (RCEL) Stock Price Target 2026

The average analyst price target for AVITA Medical is $14.50, 14.1% below the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $8 to $21. The latest change came on Nov 6, 2026, when Lake Street raised its price target on AVITA Medical from $12 to $20 and kept a Buy rating.

The Average Analyst Price Target for AVITA Medical is $14.50.

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

6Buy

1Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$14.50Upside to Avg. PT-14.1%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for AVITA Medical Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2026	Lake Street	Frank Takkinen	PT Raise	Buy	$12→$20
Nov 6, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$15→$21
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$11→$15
Aug 28, 2026	Lake Street	Frank Takkinen	PT Raise	Buy	$8→$12
Aug 19, 2026	TD Cowen	Joshua Jennings	PT Raise	Buy	$12→$14
Aug 19, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$7→$11
Aug 7, 2026	BTIG	Ryan Zimmerman	Upgrade	Neutral→Buy	$7
May 15, 2026	Lake Street	Frank Takkinen	Upgrade	Hold→Buy	$4→$6
Apr 9, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$10
Apr 8, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$10
Mar 5, 2026	Northland Capital Markets	Carl Byrnes	Initiate	Outperform	$10
Feb 17, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$10
Jan 26, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$10
Jan 16, 2026	Lake Street	Frank Takkinen	PT Raise	Hold	$3→$4
Jan 15, 2026	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$14→$10
Nov 20, 2025	BTIG	Ryan Zimmerman	Upgrade	Sell→Neutral	—
Nov 7, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$14
Oct 17, 2025	Lake Street	Frank Takkinen	Downgrade	Buy→Hold	$8→$4
Oct 17, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$14
Sep 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$14